FIELD: medicine.
SUBSTANCE: invention is aimed at SHP2 inhibitors and their use in the treatment of diseases. Pharmaceutical compositions containing these inhibitors are also disclosed.
EFFECT: obtaining compounds for the treatment of diseases.
72 cl, 1 tbl, 52 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS BASED ON SHP2 INHIBITOR AND METHODS OF CANCER TREATMENT | 2018 |
|
RU2805355C2 |
NEW ANTIMICROBIAL AGENTS | 2009 |
|
RU2522582C2 |
HISTONE DEACETYLASE INHIBITORS | 2014 |
|
RU2673819C2 |
OBTAINING DIHYDROTHIENO[3,2-d]PYRIMIDINES AND INTERMEDIATE PRODUCTS, APPLIED FOR THEIR SYNTHESIS | 2008 |
|
RU2528340C2 |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2707749C2 |
AMIDES OF QUINOLINE AND QUINAZOLINE, USEFUL AS A SODIUM CHANNEL MODULATORS | 2014 |
|
RU2683788C2 |
TRICYCLIC COMPOUNDS AS INHIBITORS OF IMMUNOSUPPRESSION MEDIATED BY TRYPTOPHAN METABOLIZATION | 2014 |
|
RU2667509C2 |
TYK2 INHIBITORS AND THEIR USE | 2019 |
|
RU2813233C2 |
ARYL, HETEROARYL AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS | 2018 |
|
RU2801278C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
Authors
Dates
2022-07-27—Published
2018-01-09—Filed